Meta Pays $200 Million To Get One AI Programmer From Apple — Positive

META   24/7 Wall Street — July 10, 2025

Meta (NASDAQ: META) wants to be the global leader in AI systems that can complete tasks at the level of humans.

image for news Meta Pays $200 Million To Get One AI Programmer From Apple

PRU Stock Trading at a Discount to Industry at 7.47X: Time to Buy? — Positive

PRU   Zacks Investment Research — July 10, 2025

Prudential Financial lags the market with a 10.1% drop but trades at a discount, backed by solid ROE and a global growth strategy.

image for news PRU Stock Trading at a Discount to Industry at 7.47X: Time to Buy?

Will Celsius' Innovation Strategy Fuel its Next Wave of Growth? — Positive

CELH   Zacks Investment Research — July 10, 2025

CELH bets big on innovation with new brands, hydration products and retail gains to reignite growth after a soft first quarter.

image for news Will Celsius' Innovation Strategy Fuel its Next Wave of Growth?

Surging Earnings Estimates Signal Upside for Cadence (CADE) Stock — Positive

CADE   Zacks Investment Research — July 10, 2025

Cadence (CADE) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

image for news Surging Earnings Estimates Signal Upside for Cadence (CADE) Stock

Approximately 99% of Shares Voted have been “FOR” the Reorganization Proposal Additional Shares Needed to Vote “FOR” to Approve the Reorganization Urges ALL Stockholders to Protect the Value of their Investment by Voting “FOR” the Reorganization Proposal TODAY OAKLAND, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (OTCQB: LOGC) (“ContextLogic,” the “Company,” “we” or “our”) today announced its Annual Meeting of Stockholders (the “Annual Meeting”) being held today will convene and then adjourn without conducting any business.

image for news ContextLogic Announces Adjournment of Annual Meeting of Stockholders to Allow Additional Time for Stockholders to Vote “FOR” the Reorganization Proposal

Conagra Brands, Inc. (CAG) Q4 2025 Pre-recorded Remarks Call Transcript — Neutral

CAG   Seeking Alpha — July 10, 2025

Conagra Brands, Inc. (NYSE:CAG ) Q4 2025 Pre-recorded Remarks Conference Call July 10, 2025 8:30 AM ET Company Participants David S. Marberger - Executive VP & CFO Matthew Neisius - Senior Director of Investor Relations Sean M.

image for news Conagra Brands, Inc. (CAG) Q4 2025 Pre-recorded Remarks Call Transcript

Goldman Sachs is the acknowledged leader in the investment landscape on Wall Street and worldwide.

image for news Goldman Sachs Starts 3 Sizzling Semiconductor Capital Equipment Dividend Stocks With Buy Ratings

United Airlines to Report Q2 Earnings: Is a Beat in Store for the Stock? — Neutral

UAL   Zacks Investment Research — July 10, 2025

Let's assess the factors that are likely to have influenced UAL's second-quarter performance.

image for news United Airlines to Report Q2 Earnings: Is a Beat in Store for the Stock?

Microsoft Outlook hit with hours-long outage — Negative

MSFT   CNBC — July 10, 2025

Microsoft's Outlook email service malfunctioned for several hours. It affected Outlook.com as well as Outlook mobile apps and desktop programs.

image for news Microsoft Outlook hit with hours-long outage

Reasons to Add Fresenius Medical Stock to Your Portfolio Now — Negative

FMS   Zacks Investment Research — July 10, 2025

FMS continues to gain traction on the back of acquisitions & partnerships. A tough regulatory environment raises concerns.

image for news Reasons to Add Fresenius Medical Stock to Your Portfolio Now

COIN Stock Trades Near 52-Week High: Buy Now or Wait for a Pullback? — Positive

COIN   Zacks Investment Research — July 10, 2025

COIN nears its 52-week high as global expansion, derivatives growth and DeFi moves fuel investor interest.

image for news COIN Stock Trades Near 52-Week High: Buy Now or Wait for a Pullback?

KRYS Begins Dosing With Gene Therapy in Rare Eye Disease, Stock Up — Neutral

KRYS   Zacks Investment Research — July 10, 2025

Krystal Biotech climbs after dosing begins in a phase I/II trial for KB801, a gene therapy eye drop targeting neurotrophic keratitis.

image for news KRYS Begins Dosing With Gene Therapy in Rare Eye Disease, Stock Up

Will Altria (MO) Beat Estimates Again in Its Next Earnings Report? — Positive

MO   Zacks Investment Research — July 10, 2025

Altria (MO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will Altria (MO) Beat Estimates Again in Its Next Earnings Report?

Will CyberArk (CYBR) Beat Estimates Again in Its Next Earnings Report? — Positive

CYBR   Zacks Investment Research — July 10, 2025

CyberArk (CYBR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will CyberArk (CYBR) Beat Estimates Again in Its Next Earnings Report?

Why NextEra (NEE) is Poised to Beat Earnings Estimates Again — Positive

NEE   Zacks Investment Research — July 10, 2025

NextEra (NEE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Why NextEra (NEE) is Poised to Beat Earnings Estimates Again

Will Philip Morris (PM) Beat Estimates Again in Its Next Earnings Report? — Positive

PM   Zacks Investment Research — July 10, 2025

Philip Morris (PM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will Philip Morris (PM) Beat Estimates Again in Its Next Earnings Report?

Will Truist Financial (TFC) Beat Estimates Again in Its Next Earnings Report? — Positive

TFC   Zacks Investment Research — July 10, 2025

Truist Financial (TFC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will Truist Financial (TFC) Beat Estimates Again in Its Next Earnings Report?

Will CME (CME) Beat Estimates Again in Its Next Earnings Report? — Positive

CME   Zacks Investment Research — July 10, 2025

CME (CME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will CME (CME) Beat Estimates Again in Its Next Earnings Report?

Will Diamondback (FANG) Beat Estimates Again in Its Next Earnings Report? — Positive

FANG   Zacks Investment Research — July 10, 2025

Diamondback (FANG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will Diamondback (FANG) Beat Estimates Again in Its Next Earnings Report?

Why Bright Horizons (BFAM) is Poised to Beat Earnings Estimates Again — Positive

BFAM   Zacks Investment Research — July 10, 2025

Bright Horizons (BFAM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Why Bright Horizons (BFAM) is Poised to Beat Earnings Estimates Again